Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Connective Therapeutics acquires rheumatoid arthritis Rx from SKB

Dec. 6, 1996

Phase II trials begin on low-dose interferon alfa for Sjogren's syndrome

Dec. 5, 1996

COX-2 inhibitors under investigation at Glaxo Wellcome

Dec. 3, 1996

Reversible cysteine protease inhibitors reported by Arris

Nov. 28, 1996

Taiho antirheumatic agent possesses novel mechanism of action

Nov. 27, 1996

Rx for Sjogren's syndrome symptoms nearing launch

Nov. 26, 1996

SKB to begin pivotal trials with antibody for RA

Nov. 22, 1996

Otsuka discloses inhibitor of TNF-alpha production

Nov. 21, 1996

Development of antiinflammatory/analgesic drug discontinued

Nov. 8, 1996

Progress on Scotia's rheumatoid arthritis treatment

Nov. 8, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026